Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncotarget.14723 http://scihub22266oqcxt.onion/10.18632/oncotarget.14723 C5386776!5386776!28107201     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncotarget 2017 ; 8 (12): 20452-61 Nephropedia Template TP {{tp|p=28107201|t=2017. Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies |pdf=|usr=}}{{28107201}} gab.com Text Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies JO: Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28107201 #FOAvip The HIPK2 (serine/threonine homeodomain-interacting protein kinase 2) is a ?caretaker? gene, its inactivation increases tumorigenicity while its activation inhibits tumor growth. This report reviews the anti-tumorigenic mechanisms of HIPK2, which include promotion of apoptosis, inhibition of angiogenesis in hypoxia, prevention of tumor invasion/metastasis and attenuation of multidrug resistance in cancer. Additionally, we summarize conditions or factors that may increase HIPK2 activity. Twit Text FOAVip Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies ????Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28107201 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28107201 #FOAvip English Wikipedia <ref>{{Cite pmid|28107201}}</ref> Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies #MMPMID28107201 Feng Y; Zhou L; Sun X; Li Q Oncotarget 2017[Mar]; 8 (12): 20452-61 PMID28107201show ga The HIPK2 (serine/threonine homeodomain-interacting protein kinase 2) is a ?caretaker? gene, its inactivation increases tumorigenicity while its activation inhibits tumor growth. This report reviews the anti-tumorigenic mechanisms of HIPK2, which include promotion of apoptosis, inhibition of angiogenesis in hypoxia, prevention of tumor invasion/metastasis and attenuation of multidrug resistance in cancer. Additionally, we summarize conditions or factors that may increase HIPK2 activity. äHomeodomain-interacting protein kinase 2 (HIPK2): a promising target f(epmc).pdf DeepDyve Pubget Overpricing